10205-70-6

Basic information

• Product Name: Benzothiazole, 6-methoxy-2-(4-methoxyphenyl)-
• CAS NO: 10205-70-6
• Molecular Formula: C15H13NO2S
• Molecular Weight: 271.34
• Mol File: 10205-70-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzothiazole, 6-methoxy-2-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzothiazole, 6-methoxy-2-(4-methoxyphenyl)-(10205-70-6)
• EPA Substance Registry System: Benzothiazole, 6-methoxy-2-(4-methoxyphenyl)-(10205-70-6)

Safety Data

• Hazardous Substances Data: 10205-70-6(Hazardous Substances Data)

Upstream product

• 123-11-5 4-methoxy-benzaldehyde 
• 104-94-9 4-methoxy-aniline 
• 5720-07-0 4-methoxyphenylboronic acid 
• 2941-58-4 2-bromo-6-methoxy-1,3 benzothiazole 
• 27865-44-7 4-methoxy-N-(4-methoxyphenyl)benzamide 
• 73011-26-4 6-methoxy-3H-benzo[d][1,2,3]dithiazole 2-oxide 
• 82020-27-7 methoxy-4 N-(methoxy-4 phenyl) thiobenzamide 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 6274-29-9 2-amino-5-methoxy-thiophenol 
• 39143-07-2 4-anisylidene-3-methyl-1-phenylpyrazol-5-one 

Relevant articles and documents

Metal-Free Synthesis of 2-Arylbenzothiazoles from Aldehydes, Amines, and Thiocyanate

A highly efficient method for the synthesis of 2-arylbenzothiazoles has been developed using readily available aromatic amines, benzaldehydes, and NH4SCN as a sulfur source. A library of 2-arylbenzothiazoles with wide functional group compatibility has been synthesized in good yields through iodine-mediated oxidative annulation.

Regioselective synthesis of diltiazem analogue pyrazolo[4,3-c][1,5] benzothiazepines and antifungal activity

A dry media procedure has been developed for the synthesis of a series of new class of pyrazolo [4,3-c][1,5]benzothiazepines 6 under microwave irradiation using montmorillonite K10 as solid support. The catalyst can be recovered and reused. Thus, the procedure provides a simple and green synthetic methodology under environmentally friendly conditions. Antifungal screening of synthesized compounds has shown promising activity. Supplemental materials are available for this article. Go to the publishers online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file. Taylor & Francis Group, LLC.

Therapeutic compounds

Compounds of the formula (I) for use as an estrogen receptor-β-selective ligand are described wherein: X is O or S; and R1, R3 R6 are as described in the specification. The use of these compounds in treating Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis, cardiovascular disease, rheumatoid arthritis and prostate cancer is described; as are processes for making them.